Published in Prim Care Companion CNS Disord on June 25, 2015
Psychiatric illness in general practice. A detailed study using a new method of case identification. Br Med J (1970) 13.12
Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol (1994) 10.17
A critical appraisal of the quality of quality-of-life measurements. JAMA (1994) 9.10
Psoriasis. N Engl J Med (2009) 8.80
Assesment of quality-of-life outcomes. N Engl J Med (1996) 8.66
Severe psoriasis--oral therapy with a new retinoid. Dermatologica (1978) 5.67
Pathogenesis and clinical features of psoriasis. Lancet (2007) 5.01
Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol (1986) 3.94
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
Training family doctors to recognise psychiatric illness with increased accuracy. Lancet (1980) 3.09
Psoriasis. Lancet (2003) 3.05
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol (2010) 2.90
Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis (2005) 2.61
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol (2008) 2.53
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest (2004) 2.34
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol (2008) 2.19
Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc (2004) 1.95
Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol (2002) 1.85
The psychosocial burden of psoriasis. Am J Clin Dermatol (2005) 1.81
The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol (1995) 1.73
Psychosocial effect of common skin diseases. Can Fam Physician (2002) 1.71
Body image and disfigurement: issues and interventions. Body Image (2004) 1.57
Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci U S A (2000) 1.39
Suicidal ideation in psoriasis. Int J Dermatol (1993) 1.37
Psychiatric morbidity in psoriasis: a review. Australas J Dermatol (2004) 1.32
Quality of life in patients with psoriasis. Health Qual Life Outcomes (2006) 1.31
Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol (2005) 1.26
Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol (2012) 1.22
Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol (2002) 1.21
Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint. Arch Dermatol (1983) 1.19
Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol (2002) 1.16
Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol (1988) 1.15
Psychiatric rating scales in Urdu: a systematic review. BMC Psychiatry (2007) 1.14
Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol (1993) 1.10
Patients with psoriasis feel stigmatized. Acta Derm Venereol (2012) 1.10
Reliability and validity of the General Health Questionnaire (GHQ-12) among urological patients: a Malaysian study. Psychiatry Clin Neurosci (2001) 1.09
Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol (2007) 1.08
The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res (2001) 1.06
Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol (2012) 1.05
Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol (2000) 1.04
Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol (1989) 1.03
The clinical spectrum of psoriasis. Clin Dermatol (2007) 1.02
Role of depression in quality of life for patients with psoriasis. Dermatology (2007) 1.02
Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry (2007) 1.02
Quality of life issues in psoriasis. J Am Acad Dermatol (2003) 1.02
Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol (2002) 1.00
A hassle a day may keep the doctor away: stress and the augmentation of immune function. Integr Comp Biol (2002) 1.00
Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics (2005) 0.95
Stress, social support, and delayed skin barrier recovery. Psychosom Med (2007) 0.93
The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res (2002) 0.93
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol (2013) 0.93
Moderate and severe plaque psoriasis: cost-of-illness study in Italy. Ther Clin Risk Manag (2008) 0.93
The skin and the mind. Aust Fam Physician (2006) 0.91
Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). Br J Dermatol (2014) 0.90
Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res (2012) 0.90
Quality of life indices. Indian J Dermatol Venereol Leprol (2007) 0.89
Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience. Clin Dermatol (2007) 0.87
Factor structure of the General Health Questionnaire (GHQ-12) in subjects who had suffered from the 2004 Niigata-Chuetsu Earthquake in Japan: a community-based study. BMC Public Health (2007) 0.86
Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol (2009) 0.85
Alcohol and skin disorders: with a focus on psoriasis. Skin Therapy Lett (2011) 0.84
Clinical spectrum and severity of psoriasis. Curr Probl Dermatol (2009) 0.83
Relevance of psychiatry in dermatology: Present concepts. Indian J Psychiatry (2010) 0.83
The clinical domains of psychosomatic medicine. J Clin Psychiatry (2005) 0.82
The economic burden of skin disease in the United States. J Am Acad Dermatol (2003) 0.81
The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med (2009) 0.81
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol (2009) 0.81
Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol (2006) 0.80
Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol (2005) 0.80
Nail psoriasis as a severity indicator: results from the PsoReal study. Patient Relat Outcome Meas (2010) 0.80
Patients' strategies for coping with psoriasis. Clin Exp Dermatol (2002) 0.79
The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int J Dermatol (2010) 0.79
Assessing quality of life in older adult patients with skin disorders. Glob J Health Sci (2012) 0.78
Emotional intelligence as an indicator of satisfaction with life of patients with psoriasis. Postepy Dermatol Alergol (2013) 0.78
Patients seen in a dermatology clinic have unmet preventive health care needs. J Am Acad Dermatol (2001) 0.77
Determinants of quality of life in psoriasis patients: a cluster analysis of 50 patients. Indian J Dermatol (2011) 0.77
Our experience in a psychodermatology liaison clinic at manipal, India. Indian J Dermatol (2013) 0.77
Quality of life assessment: values and pitfalls. J R Soc Med (1995) 0.76
Quality-of-life issues in psoriasis. Dermatol Clin (2004) 0.76
Psychological interventions in dermatology. Indian J Dermatol (2013) 0.76
Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis. Indian J Dermatol Venereol Leprol (2008) 0.75
Malaysian Psoriasis Registry--preliminary report of a pilot study using a newly revised registry form. Med J Malaysia (2008) 0.75